Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Meta-analysis of Somatic Mutations from Next Generation Sequencing of 241 Melanomas: A Road Map for the Study of Genes with Potential Clinical Relevance
Junfeng Xia, Peilin Jia, Katherine E. Hutchinson, et al.
Molecular Cancer Therapeutics (2014) Vol. 13, Iss. 7, pp. 1918-1928
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Mechanisms and prevention of UV‐induced melanoma
Ashley Sample, Yu‐Ying He
Photodermatology Photoimmunology & Photomedicine (2017) Vol. 34, Iss. 1, pp. 13-24
Open Access | Times Cited: 273
Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B
Peiling Chen, A. Chaikuad, Paul Bamborough, et al.
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 4, pp. 1410-1424
Open Access | Times Cited: 154
Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes
Feixiong Cheng, Junfei Zhao, Zhongming Zhao
Briefings in Bioinformatics (2015) Vol. 17, Iss. 4, pp. 642-656
Open Access | Times Cited: 140
Ras activation revisited: role of GEF and GAP systems
Anne K. Hennig, Robby Markwart, Manuel A. Esparza-Franco, et al.
Biological Chemistry (2015) Vol. 396, Iss. 8, pp. 831-848
Closed Access | Times Cited: 125
MITF and UV responses in skin: From pigmentation to addiction
Nhu T. Nguyen, David E. Fisher
Pigment Cell & Melanoma Research (2018) Vol. 32, Iss. 2, pp. 224-236
Open Access | Times Cited: 122
Beyond BRAF: where next for melanoma therapy?
Inna V. Fedorenko, Geoffrey T. Gibney, Vernon K. Sondak, et al.
British Journal of Cancer (2014) Vol. 112, Iss. 2, pp. 217-226
Open Access | Times Cited: 103
The miRNAs Role in Melanoma and in Its Resistance to Therapy
Francesca Varrone, Emilia Caputo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 878-878
Open Access | Times Cited: 71
Research progress of microneedles in the treatment of melanoma
Xiaodan Li, Zhining Zhao, Manyue Zhang, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 631-647
Closed Access | Times Cited: 58
Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat
Erin E. Resch, Stavriani C. Makri, Paola Ghanem, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion
Alexander M. Menzies, Iwei Yeh, Thomas Botton, et al.
Pigment Cell & Melanoma Research (2015) Vol. 28, Iss. 5, pp. 607-610
Open Access | Times Cited: 82
Genetics of melanoma progression: the rise and fall of cell senescence
Dorothy C. Bennett
Pigment Cell & Melanoma Research (2015) Vol. 29, Iss. 2, pp. 122-140
Open Access | Times Cited: 82
Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial
Terry A. Day, Keisuke Shirai, Paul E. O’Brien, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 4, pp. 1156-1164
Open Access | Times Cited: 79
Frequency of mutations in BRAF, NRAS, and KIT in different populations and histological subtypes of melanoma: a systemic review
Luz Dary Gutiérrez-Castañeda, John Nova, José D. Tovar-Parra
Melanoma Research (2019) Vol. 30, Iss. 1, pp. 62-70
Open Access | Times Cited: 72
Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel
Blanca de Unamuno Bustos, Rosa Murria Estal, Gema Pérez Simó, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 68
Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071
Sophie Piperno‐Neumann, James Larkin, Richard D. Carvajal, et al.
Molecular Cancer Therapeutics (2020) Vol. 19, Iss. 4, pp. 1031-1039
Open Access | Times Cited: 51
Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
Jinfeng Cao, Renier C. Heijkants, Aart G. Jochemsen, et al.
Oncotarget (2016) Vol. 8, Iss. 35, pp. 58021-58036
Open Access | Times Cited: 57
Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014
Paolo A. Ascierto, Michael B. Atkins, Carlo Bifulco, et al.
Journal of Translational Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma
Michael T. Tetzlaff, Penvadee Pattanaprichakul, Jennifer A. Wargo, et al.
Human Pathology (2015) Vol. 46, Iss. 8, pp. 1101-1110
Open Access | Times Cited: 50
Kinase gene fusions in defined subsets of melanoma
Jacqueline A. Turner, Kasey L. Couts, Jamie Sheren, et al.
Pigment Cell & Melanoma Research (2016) Vol. 30, Iss. 1, pp. 53-62
Open Access | Times Cited: 47
Dysregulation of Mg2+ homeostasis contributes to acquisition of cancer hallmarks
Valentina Trapani, Federica I. Wolf
Cell Calcium (2019) Vol. 83, pp. 102078-102078
Open Access | Times Cited: 43
Genetic alterations in seborrheic keratoses
Barbara Heidenreich, Evgeniya Denisova, P. Sivaramakrishna Rachakonda, et al.
Oncotarget (2017) Vol. 8, Iss. 22, pp. 36639-36649
Open Access | Times Cited: 44
Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
Ugo Testa, Germana Castelli, Elvira Pelosi
Medical Sciences (2017) Vol. 5, Iss. 4, pp. 28-28
Open Access | Times Cited: 40
AMPK promotes survival of c‐Myc‐positive melanoma cells by suppressing oxidative stress
Alain Kfoury, Marzia Armaro, Caterina Collodet, et al.
The EMBO Journal (2018) Vol. 37, Iss. 5
Open Access | Times Cited: 36
Feedback activation of neurofibromin terminates growth factor-induced Ras activation
Anne K. Hennig, Robby Markwart, Katharina Wolff, et al.
Cell Communication and Signaling (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Biology and Treatment of BRAF Mutant Metastatic Melanoma
Benjamin Y. Kong, Matteo S. Carlino, Alexander M. Menzies
Melanoma Management (2016) Vol. 3, Iss. 1, pp. 33-45
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top